MITO-RELATED CLINICAL STUDY UPDATE:
COVID-19 Pandemic Impact at Clinical Sites Delays Study MENLO PARK, Calif., March 30, 2020 (GLOBE NEWSWIRE) — CohBar, Inc. ( CWBR ), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, today announced that it is anticipating delays in the completion […]